ARDELYX INC (ARDX)
US0396971071 - Common Stock
ARDX Makes Notable Cross Below Critical Moving Average
Ardelyx, Inc. Reports Employment Inducement Grants
Ardelyx, Inc. Reports Employment Inducement Grants
WALTHAM, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop...
Medical Moonshots: 3 Biotech Stocks Set to Skyrocket
Though risky, investors who buy biotech stocks watch their portfolios skyrocket when their drugs work as intended.
Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference
Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference
WALTHAM, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop...
Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults
WALTHAM, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop...
The 3 Best Penny Stocks to Buy in May 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Penny stocks are classified as stocks that trade for less than $5 and are typic...
The 3 Best Penny Stocks to Buy in May 2024
Ride the momentum with these affordable penny stocks as they continue to display for solid profits this year.
Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
WALTHAM, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop...
7 Cheap Penny Stocks to Buy Now: May 2024
Discover seven penny stocks poised for significant gains in 2024. Explore opportunities in cannabis, mining, EVs, and more.
Ardelyx, Inc. Reports Employment Inducement Grants
Ardelyx, Inc. Reports Employment Inducement Grants
WALTHAM, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop...
Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference
WALTHAM, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop...
Notable Friday Option Activity: CROX, ARDX, PPC
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are worth checking out this morning as we dive into all of the biggest news moving shares on Friday!
ARDX Stock Earnings: Ardelyx Beats EPS, Beats Revenue for Q1 2024
ARDX stock results show that Ardelyx beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
ARDX Stock Earnings: Ardelyx Beats EPS, Beats Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ardelyx (NASDAQ:ARDX) just reported results for the first quarter of 2024.Ardel...
Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update
Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update
Company reports $45.6 million in Q1 product-related revenue, including $28.4 million in net product sales revenue for IBSRELA and $15.2 million in net...
Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings
WALTHAM, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop...
Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024
Conference call scheduled for 4:30 p.m. Eastern Time